Credit Suisse’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
RJFSA
RJA
BFG
Credit Suisse's FBT Position: Q2 2023 in Review
Credit Suisse sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2023, closing a stake of 2,126 shares — an estimated $330K sold.
Credit Suisse first reported a position in FBT in Q2 2013 and held it in 21 quarters. The position peaked at $8.99M in Q2 2015. 249 funds tracked by Wall St. Rank hold FBT as of Q2 2023.
- Credit Suisse reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2023 after selling out during the quarter.
- Credit Suisse sold 2,126 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2023, an estimated $330K.
- Credit Suisse first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 21 quarters.
- Credit Suisse's First Trust NYSE Arca Biotechnology Index Fund position peaked at $8.99M in Q2 2015.
- 249 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2023.
Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.